Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Phase 2 Completed
50 enrolled
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
Phase 1 Completed
18 enrolled
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Phase 1/2 Terminated
17 enrolled 7 charts
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Phase 1 Completed
7 enrolled
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
Phase 1 Terminated
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Completed
56 enrolled
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Phase 1 Completed
15 enrolled
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Completed
40 enrolled
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
Completed
60 enrolled
Protein Expression in Samples From Young Patients With Rhabdomyosarcoma
Completed
77 enrolled
Studying Tumor Tissue Samples From Patients With Soft Tissue Sarcoma
Completed
27 enrolled
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
Phase 2 Completed
38 enrolled